Pease H. Flavia's most recent trade in Charles River Laboratories International Inc. was a trade of 7,152 Common Stock done at an average price of $135.6 . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 135.63 per share. | 30 May 2025 | 7,152 | 17,482 (0%) | 0% | 135.6 | 970,026 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.63 per share. | 30 May 2025 | 185 | 17,297 (0%) | 0% | 135.6 | 25,092 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.73 per share. | 26 May 2025 | 190 | 10,471 (0%) | 0% | 136.7 | 25,979 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.73 per share. | 26 May 2025 | 141 | 10,330 (0%) | 0% | 136.7 | 19,279 | Common Stock |
| Insulet | Flavia H. Pease | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 778 | 3,629 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.89 per share. | 02 May 2025 | 889 | 10,661 (0%) | 0% | 116.9 | 103,915 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 2,704 | 12,464 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.57 per share. | 31 Jan 2025 | 914 | 11,550 (0%) | 0% | 165.6 | 151,331 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 4,906 | 4,906 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 2,159 | 9,760 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 212 | 7,795 (0%) | 0% | 217.2 | 46,049 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 212 | 7,795 (0%) | 0% | 217.2 | 46,049 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 194 | 7,601 (0%) | 0% | 217.2 | 42,139 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 144 | 7,651 (0%) | 0% | 217.2 | 31,278 | Common Stock |
| Insulet | Flavia H. Pease | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,380 | 2,851 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.69 per share. | 02 May 2024 | 893 | 8,007 (0%) | 0% | 232.7 | 207,792 | Common Stock |
| Insulet | Pease H. Flavia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 1,471 | 1,471 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 5,314 | 5,314 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 2,215 | 9,037 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 137 | 8,900 (0%) | 0% | 194.1 | 26,594 | Common Stock |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 4,423 | 4,423 | - | - | Stock Options (Right to Buy) | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,637 | 6,822 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 5,185 | 5,185 (0%) | 0% | 0 | Common Stock | |
| Charles River Labs | Flavia H. Pease | Corporate Executive VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 4,649 | 4,649 | - | - | Stock Options (Right to Buy) |